Abstract: Provided is a squamous cell carcinoma antigen derived peptide which is capable of binding to an HLA-A24 molecule and recognized by the cellular immune system, and a pharmaceutical composition comprising said peptide for the treatment or prevention of squamous cell carcinoma.

Abstract: An object of the invention is to provide a peptide derived from a glioma-associated antigen being useful for the specific immunotherapy for glioma patients. The invention provides a KIF-derived peptide which is capable of binding to an HLA-A24 molecule and recognized by the cellular immune system, and a pharmaceutical composition comprising said peptide for the treatment or prevention of glioma.

Abstract: According to the present invention, a peptide, which is a prostate-related protein derived peptide, capable of binding to an HLA-A3 supertype allele and recognized by the cellular and/or humoral immune system is provided. The peptides of the present invention make feasible the peptide-based anti-cancer vaccine therapy for prostate cancer patients with HLA-A3 supertype allele and useful for the treatment of prostate cancer patients with alleles other than HLA-A2 and -A24 to which cancer vaccine peptide candidates had been identified.

Abstract: An object of the invention is to provide a peptide derived from a glioma-associated antigen being useful for the specific immunotherapy for glioma patients. The invention provides a KIF-derived peptide which is capable of binding to an HLA-A24 molecule and recognized by the cellular immune system, and a pharmaceutical composition comprising said peptide for the treatment or prevention of glioma.

Abstract: Provided is a squamous cell carcinoma antigen derived peptide which is capable of binding to an HLA-A24 molecule and recognized by the cellular immune system, and a pharmaceutical composition comprising said peptide for the treatment or prevention of squamous cell carcinoma.

Abstract: A cancer antigen peptide which is a partial peptide derived from parathyroid hormone-related protein, and which is capable of binding to an HLA-A24 or HLA-A2 antigen and being recognized by cytotoxic T lymphocytes, or a derivative thereof having the functionally equivalent properties, can be useful for the treatment and prevention of prostate cancer.

Abstract: The invention provides an elevator apparatus comprising a cage 1 disposed inside a path of upward or downward movement vertically movably, a counterweight 2 vertically movable with the upward or downward movement of the cage 1, and a lift drive mechanism for driving the cage 1 upward or downward. The drive mechanism comprises a sheave 42 disposed inside the path, ropes 3 extending along a route around the sheave 42, and a drive device 5 in engagement with the ropes 3. The drive device 5 comprises a belt transmission provided alongside the ropes 3 and revolvingly movable along the rope extension route, a mechanism for pressing a belt surface of the belt transmission into contact with the ropes 3, and a drive motor for driving the belt transmission. The cage can be driven upward or downward without using any traction sheave, while the cage can be reduced in weight.

Abstract: A cancer antigen peptide comprising an amino acid sequence shown in SEQ ID NO: 1 or 2, or a derivative thereof having the functionally equivalent property is provided. The provided cancer antigen peptide is a partial peptide derived from enhancer of zeste homolog 2, which is capable of binding to HLA-A24 antigen and is recognized by cytotoxic T lymphocytes. The cancer antigen peptide of the invention is useful for treatment and prevention of prostate cancer.

Abstract: A cancer antigen peptide comprising an amino acid sequence shown in SEQ ID NO: 1 or 2, or a derivative thereof having the functionally equivalent property is provided. The provided cancer antigen peptide is a partial peptide derived from enhancer of zeste homolog 2, which is capable of binding to HLA-A24 antigen and is recognized by cytotoxic T lymphocytes. The cancer antigen peptide of the invention is useful for treatment and prevention of prostate cancer.

Abstract: The invention provides an elevator apparatus comprising a cage 1 disposed inside a path of upward or downward movement vertically movably, a counterweight 2 vertically movable with the upward or downward movement of the cage 1, and a lift drive mechanism for driving the cage 1 upward or downward. The drive mechanism comprises a sheave 42 disposed inside the path, ropes 3 extending along a route around the sheave 42, and a drive device 5 in engagement with the ropes 3. The drive device 5 comprises a belt transmission provided alongside the ropes 3 and revolvingly movable along the rope extension route, a mechanism for pressing a belt surface of the belt transmission into contact with the ropes 3, and a drive motor for driving the belt transmission. The cage can be driven upward or downward without using any traction sheave, while the cage can be reduced in weight.

Abstract: A winding machine for coil bobbins in which a one-piece or divided index carriage is reciprocally movable in its axial direction and reversibly rotatable about the axis. A plurality of slide plates are supported on the carriage for reciprocally slidable movement axially along the carriage and equally angularly spaced from each other, a plurality of bobbin mount jigs project outwardly in one row from each of the slide plates in equally spaced relationship, and a plurality of part guide members corresponding in number to the number of the bobbin mount jigs are provided to guide wire onto and about bobbins loaded on the bobbin mount jigs. A common soldering unit solders wire to the bobbins, a common bobbin feed unit is provided to feed bobbins to the jigs, a product discharge mechanism discharges complete full coil bobbins from the machine and a cut unit is optionally provided to cut wire to a predetermined length.